J Korean Med Sci.  2010 Aug;25(8):1217-1221. 10.3346/jkms.2010.25.8.1217.

Characteristics of 681 Low Vision Patients in Korea

• Kim JH
• Joo KS
• Moon NJ

• KMID: 1714046
• DOI: http://doi.org/10.3346/jkms.2010.25.8.1217

Abstract

The purpose of our study was to evaluate the characteristics and the changes of low vision patients over ten years in Korea, and to establish useful data for planning low vision services, active care and rehabilitation. We conducted a retrospective study of 681 low vision patients who visited two low vision clinics in Seoul from 1995 to 2008. Age and sex distribution, cause of low vision, type of prescribed low vision aids, and changes of the characteristics were reviewed. In result, male were more than female. The age group between 11 and 20-yr-old (18.1%) was the largest age group. Optic atrophy (28.3%) was main causes of low vision. However, elderly low vision patients is increasing and macular degeneration is becoming a leading cause of low vision (P<0.05). One thousand five low vision aids (LVAs) were prescribed for 681 patients (1.46+/-0.62 aids for each patient). Near LVAs were prescribed more than distance LVAs. In most patients, the use of LVAs improved both near and distance visual function. This study is the first survey of a large number of low vision patients over a ten year period in Korea. On the base of this study, the planning of low vision services and more active rehabilitation for low vision patients, especially elderly patients, need in Korea.

Keyword

Low Vision; Rehabilitation; Visual Function

MeSH Terms

Adolescent
Adult
Age Distribution
Age Factors
Aged
Aged, 80 and over
Child
Child, Preschool
Female
Humans
Macular Degeneration/complications
Male
Middle Aged
Optic Atrophy/complications
Republic of Korea
Retrospective Studies
Sex Factors
Vision, Low/*etiology

Reference

1. World Health Organization. WHO/PBL/93.27. The Management of Low Vision in Children. Report of a WHO Consultation: Bangkok, July 1992. 1993. Geneva: World Health Organization.

2. World Health Organization. WHO/PBL/97.61. Global Initiative for the Elimination of Avoidable Blindness. 1997. Geneva: World Health Organization.

3. Ministry for Health, Welfare and Family Affairs. The Yearbook of Ministry for Health Welfare and Family Affairs Statics. 2008. 232.

4. Congdon N, O'Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004. 122:477–485.

5. Ji YH, Park HJ, Oh SY. Clinical effect of low vision aids. Korean J Ophthalmol. 1999. 13:52–56.

6. Hyman L, Wu SY, Connell AM, Schachat A, Nemesure B, Hennis A, Leske MC. Prevalence and causes of visual impairment in the Barbados Eye Study. Ophthalmology. 2001. 108:1751–1756.

7. Michon JJ, Lau J, Chan WS, Ellwein LB. Prevalence of visual impairment, blindness, and cataract surgery in the Hong Kong elderly. Br J Ophthalmol. 2002. 86:133–139.

8. Moser CL, Martin-Baranera M, Vega F, Draper V, Gutiérrez J, Mas J. Survey of blindness and visual impairment in Bioko, Equatorial Guinea. Br J Ophthalmol. 2002. 86:257–260.

9. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol. 1990. 108:286–290.

10. Klein R, Klein BE, Linton KL, De Mets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991. 98:1310–1315.

11. Baasanhu J, Johnson GJ, Burendei G, Minassian DC. Prevalence and causes of blindness and visual impairment in Mongolia: a survey of populations aged 40 years and older. Bull World Health Organ. 1994. 72:771–776.

12. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996. 103:357–364.

13. Taylor HR, Livingston PM, Stanislavsky YL, McCarty CA. Visual impairment in Australia: distance visual acuity, near vision, and visual field findings of the Melbourne Visual Impairment Project. Am J Ophthalmol. 1997. 123:328–337.

14. Rubin GS, West SK, Munoz B, Bandeen-Roche K, Zeger S, Schein O, Fried LP. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci. 1997. 38:557–568.

15. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998. 116:653–658.

16. Dandona L, Dandona R, Srinivas M, Giridhar P, Vilas K, Prasad MN, John RK, McCarty CA, Rao GN. Blindness in the Indian state of Andhra Pradesh. Invest Ophthalmol Vis Sci. 2001. 42:908–916.

17. VanNewkirk MR, Weih L, McCarty CA, Taylor HR. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology. 2001. 108:960–967.

18. Liu JH, Cheng CY, Chen SJ, Lee FL. Visual impairment in a Taiwanese population: prevalence, causes, and socioeconomic factors. Ophthalmic Epidemiol. 2001. 8:339–350.

19. Murthy GV, Gupta S, Ellwein LB, Munoz SR, Bachani D, Dada VK. A population-based eye survey of older adults in a rural district of Rajasthan: I. Central vision impairment, blindness, and cataract surgery. Ophthalmology. 2001. 108:679–685.

20. Munoz B, West SK, Rodriguez J, Sanchez R, Broman AT, Snyder R, Klein R. Blindness, visual impairment and the problem of uncorrected refractive error in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci. 2002. 43:608–614.

21. Buch H, Vinding T, La Cour M, Appleyard M, Jensen GB, Nielsen NV. Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology. 2004. 111:53–61.

22. Dandona R, Dandona L, Srinivas M, Giridhar P, Nutheti R, Rao GN. Planning low vision services in India: a population-based perspective. Ophthalmology. 2002. 109:1871–1878.